MicroRNAs, wild-type and mutant p53 More questions than answers

被引:44
作者
Jones, Matthew Fletcher [1 ]
Lal, Ashish [1 ]
机构
[1] NCI, Genet Branch, NIH, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
miRNA; p53; mutant p53; wild-type p53; cancer; miRNA dysregulation; EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR-SUPPRESSOR P53; DOWN-REGULATION; MIR-200; FAMILY; E-CADHERIN; MIR-34A CONTRIBUTES; NEGATIVE REGULATION; TARGET RECOGNITION; CELL-PROLIFERATION; MIR-17-92; CLUSTER;
D O I
10.4161/rna.20146
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The tumor suppressor p53 is a sequence-specific transcription factor that activates the expression of genes involved in apoptosis, cell cycle arrest and senescence. p53 can also inhibit gene expression and this effect is partly mediated by inducing several microRNAs (miRNAs). MiRNAs have emerged as a new class of regulators of the expression and function of eukaryotic genomes. Tumor suppressive or oncogenic functions have been attributed to some miRNAs. Recent studies have shown that p53 can alter the transcription of several miRNAs, and in some cases, it can also influence miRNA maturation. Conversely, miRNAs can also modulate the abundance and activity of p53 by direct or indirect mechanisms. Moreover, mutant p53 can actively repress the expression of some miRNAs that are activated by wild-type p53. In this review, we discuss recent evidences of this crosstalk between miRNAs and the p53 network and also highlight its implications in cancer.
引用
收藏
页码:781 / 791
页数:11
相关论文
共 156 条
  • [1] The functions of animal microRNAs
    Ambros, V
    [J]. NATURE, 2004, 431 (7006) : 350 - 355
  • [2] The impact of microRNAs on protein output
    Baek, Daehyun
    Villen, Judit
    Shin, Chanseok
    Camargo, Fernando D.
    Gygi, Steven P.
    Bartel, David P.
    [J]. NATURE, 2008, 455 (7209) : 64 - U38
  • [3] p53-dependent Induction of PVT1 and miR-1204
    Barsotti, Anthony M.
    Beckerman, Rachel
    Laptenko, Oleg
    Huppi, Konrad
    Caplen, Natasha J.
    Prives, Carol
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (04) : 2509 - 2519
  • [4] MicroRNAs: Target Recognition and Regulatory Functions
    Bartel, David P.
    [J]. CELL, 2009, 136 (02) : 215 - 233
  • [5] MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004)
    Bartel, David P.
    [J]. CELL, 2007, 131 (04) : 11 - 29
  • [6] Evolution of microRNA diversity and regulation in animals
    Berezikov, Eugene
    [J]. NATURE REVIEWS GENETICS, 2011, 12 (12) : 846 - 860
  • [7] Post-translational modification of p53 in tumorigenesis
    Bode, AM
    Dong, ZG
    [J]. NATURE REVIEWS CANCER, 2004, 4 (10) : 793 - 805
  • [8] p53 activates the PANK1/miRNA-107 gene leading to downregulation of CDK6 and p130 cell cycle proteins
    Boehlig, Levin
    Friedrich, Maik
    Engeland, Kurt
    [J]. NUCLEIC ACIDS RESEARCH, 2011, 39 (02) : 440 - 453
  • [9] p53-mediated activation of miRNA34 candidate tumor-suppressor genes
    Bommer, Guido T.
    Gerin, Isabelle
    Feng, Ying
    Kaczorowski, Andrew J.
    Kuick, Rork
    Love, Robert E.
    Zhai, Yali
    Giordano, Thomas J.
    Qin, Zhaohui S.
    Moore, Bethany B.
    MacDougald, Ormond A.
    Cho, Kathleen R.
    Fearon, Eric R.
    [J]. CURRENT BIOLOGY, 2007, 17 (15) : 1298 - 1307
  • [10] MicroRNA-143 reduces viability and increases sensitivity to 5-fluorouracil in HCT116 human colorectal cancer cells
    Borralho, Pedro M.
    Kren, Betsy T.
    Castro, Rui E.
    da Silva, Isabel B. Moreira
    Steer, Clifford J.
    Rodrigues, Cecilia M. P.
    [J]. FEBS JOURNAL, 2009, 276 (22) : 6689 - 6700